Surrozen, Inc. (SRZN) financial statements and ratios from SEC XBRL: revenue $3.48M (TTM), net margin -6960.8%, revenue growth -67.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.48M |
| Net Margin | -6960.8% |
| Revenue Growth (YoY) | -67.4% |
| EPS Growth (YoY) | 49.4% |
| FCF Growth (YoY) | 72.0% |
| Price / Sales | 35.00 |
| FCF Yield | -22.2% |
| Altman Z-Score | -7.28 (distress) |
| Sector P/E (Healthcare) | 21.7 |
SRZN overview · SRZN earnings · SRZN KPIs · SRZN investor relations · SRZN ownership · SRZN peers · SRZN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.